Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines

Cancer Research

Volumn 63, Issue 6, 2003, Pages 1183-1187

  Sevignani, Cinzia ^a   Calin, George A ^a   Cesari, Rossano ^a   Sarti, Manuela ^a   Ishii, Hideshi ^a   Yendamuri, Sai ^a   Vecchione, Andrea ^a   Trapasso, Francesco ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CYTOCHROME C;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENICITY; CELL PERMEABILIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FRAGILE HISTIDINE TRIAD; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MITOCHONDRION; NUDE MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ADENOVIRIDAE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037444152     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Couch, F. J. and Weber, B. L. Breast cancer, In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 537-563. New York: McGraw-Hill, 1998.
2. Huebner, K., and Croce, C. M. FRA3B and other common fragile sites: the weakest links. Nat. Rev. Cancer, 1: 214-221, 2001.
3. Panagopoulos, I., Pandis, N., Thelin, S., Petersson, C., Mertens, F., Borg, A., Kristoffersson, U., Mitelman, F., and Aman, P. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res., 56: 4871-4875, 1996.
4. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
5. Hayashi, S., Tanimoto, K., Hajiro-Nakanishi, K., Tsuchiya, E., Kurosumi, M., Higashi, Y., Imai, K., Suga, K., and Nakachi, K. Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res., 57: 1981-1985, 1997.
6. Ingvarsson, S., Agnarsson, B. A., Sigbjornsdottir, B. I., Kononen, J., Kallioniemi, O. P., Barkardottir, R. B., Kovatich, A. J., Schwarting, R., Hauck, W. W., Huebner, K., and McCue, P. A. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Cancer Res., 59: 2682-2689, 1999.
7. Turner, B. C., Ottey, M., Zimonjic, D. B., Potoczek, M., Hauck, W. W., Pequignot, E., Keck-Waggoner, C. L., Sevignani, C., Aldaz, C. M., McCue, P. A., Palazzo, J., Huebner, K., and Popescu, N. C. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. Cancer Res., 62: 4054-4060, 2002.
8. Sard, L., Accornero, P., Tornielli, S., Delia, D., Bunone, G., Campiglio, M., Colombo. M. P., Gramegna, M., Croce, C. M., Pierotti, M. A., and Sozzi, G. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc. Natl. Acad. Sci. USA, 96: 8489-8492, 1999.
9. Ishii, H., Dumon, K. R., Vecchione, A., Trapasso, F., Mimori, K., Alder, H., Mori, M., Sozzi, G., Baffa, R., Huebner, K., and Croce, C. M. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res., 61: 1578-1584, 2001.
10. Ji, L., Fang, B., Yen, N., Fong, K., Minna, J. D., and Roth, J. A. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Cancer Res., 59: 3333-3339, 1999.
11. Roz, L., Gramegna, M., Ishii, H., Croce, C. M., and Sozzi, G. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc. Natl. Acad. Sci. USA, 99: 3615-3620, 2002.
12. Dumon, K. R., Ishii, H., Vecchione, A., Trapasso, F., Baldassarre, G., Chakrani, F., Druck, T., Rosato, E. F., Williams, N. N., Baffa, R., During, M. J., Huebner, K., and Croce, C. M. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res., 61, 4827-4836, 2001.
13. Ishii, H., Dumon, K. R., Vecchione, A., Fong, L. Y., Baffa, R., Huebner, K., and Croce, C. M. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies. JAMA, 286: 2441-2449, 2001.
14. Ausubel, F. M., Brent, R., Kingston, R. E., Moor, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Analysis of proteins. In: Current Protocols in Molecular Biology, pp. 10.1-10.20. New York: Greene Publishing Associates and Wiley-Interscience, 1989.
15. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S. X., Lonning, P. E., Borresen-Dale, A. L., Brown, P. O., and Botstein, D. Molecular portraits of human breast tumours. Nature (Lond.), 406: 747-752, 2000.
16. Yang, Q., Yoshimura, G., Sakurai, T., and Kakudo, K. The fragile histidine triad gene and breast cancer. Med. Sci. Monit., 8: RA140-RA144, 2002.
17. Ingvarsson, S. FHIT alterations in breast cancer. Semin. Cancer Biol., 11, 361-366, 2001.
18. Porter, A.G., and Janicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ., 6: 99-104, 1999.
19. Kumar, S., and Vaux, D. L. Apoptosis: a Cinderella caspase takes center stage. Science (Wash. DC), 297: 1290-1291, 2002.
20. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78: 739-750, 1994.
21. Lassus, P., Opitz-Araya, X., and Lazebnik, Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science (Wash. DC), 297: 1352-1354, 2002.